Co-diagnostics | 4:持股变动声明-董事 NELSON JAMES B
Co-diagnostics | 4:持股变动声明-董事 Durenard Eugene
Co-diagnostics | 4:持股变动声明-董事 SERBIN RICHARD S
Co-diagnostics | 4:持股变动声明-董事 MURPHY TED
Co-diagnostics | 4:持股变动声明-高管 Egan Dwight H
Co-diagnostics | 4:持股变动声明-高管 Brown Brian Lee
Co-diagnostics | 10-Q:季度报表
Co-diagnostics | 8-K:Co-Diagnostics, Inc. 公布2024年第一季度财务业绩
Co-diagnostics | 4:持股变动声明-高管 Abbott Richard David
Co-diagnostics | 4:持股变动声明-高管 Brown Brian Lee
Co-diagnostics | 4:持股变动声明-高管 Egan Dwight H
Co-diagnostics | 4:持股变动声明-董事 Durenard Eugene
Co-diagnostics | 4:持股变动声明-董事 NELSON JAMES B
Co-diagnostics | 4:持股变动声明-董事 MURPHY TED
Co-diagnostics | 4:持股变动声明-董事 SERBIN RICHARD S
Co-diagnostics | 3:首次持股声明-高管 Abbott Richard David
Co-diagnostics | 8-K:重大事件
Co-diagnostics | 10-K:年度报表
Co-diagnostics | 8-K:重大事件
Co-diagnostics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.82%)
暂无数据